West Pharmaceutical Services Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名28/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價345.24。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
West Pharmaceutical Services Inc評分
相關信息
行業排名
28 / 208
全市場排名
97 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
18
分析師
買入
評級
345.245
目標均價
+28.31%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
West Pharmaceutical Services Inc亮點
亮點風險
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
公司代碼WST
公司West Pharmaceutical Services Inc
CEOGreen (Eric Mark)
網址https://www.westpharma.com/
常見問題
West Pharmaceutical Services Inc(WST)的當前股價是多少?
West Pharmaceutical Services Inc(WST)的當前股價是 272.440。
West Pharmaceutical Services Inc 的股票代碼是什麼?
West Pharmaceutical Services Inc的股票代碼是WST。
West Pharmaceutical Services Inc股票的52週最高點是多少?
West Pharmaceutical Services Inc股票的52週最高點是348.900。
West Pharmaceutical Services Inc股票的52週最低點是多少?
West Pharmaceutical Services Inc股票的52週最低點是187.430。